Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Enochian Biosciences Inc (ENOB)

Enochian Biosciences Inc (ENOB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Enochian Biosciences Inc 2080 Century Park East Suite 906 Los Angeles CA 90067 USA

P: 305-918-1980

Description:

Enochian BioSciences Inc. engages in the research and development, manufacturing and clinical trials of pharmaceutical and biological products for the human treatment of HIV and cancer. The company's product pipeline consists of ENO-1001, ENO-2001, ENO-3001, ENO-1002, ENO-5001 and ENO-4001. Enochian BioSciences Inc. is based in Los Angeles, United States.

Key Statistics

Overview:

Market Capitalization, $K 146,672
Enterprise Value, $K 146,672
Shares Outstanding, K 52,950
Annual Sales, $ 0 K
Annual Net Income, $ -26,720 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,201 K
60-Month Beta 1.03
% of Insider Shareholders 39.71%
% of Institutional Shareholders 4.70%
Float, K 31,924
% Float 60.29%
Short Volume Ratio 0.69

Growth:

1-Year Return -55.54%
3-Year Return -41.19%
5-Year Return 10.36%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.12 on 05/13/22
Next Earnings Date 09/23/22
Earnings Per Share ttm -0.45
EPS Growth vs. Prev Qtr 7.69%
EPS Growth vs. Prev Year -33.33%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ENOB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -24.27%
Return-on-Assets % -22.02%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.87
Book Value/Share 0.00
Interest Coverage -69.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar